140 related articles for article (PubMed ID: 30804430)
1. Ezrin promotes breast cancer progression by modulating AKT signals.
Li N; Kong J; Lin Z; Yang Y; Jin T; Xu M; Sun J; Chen L
Br J Cancer; 2019 Apr; 120(7):703-713. PubMed ID: 30804430
[TBL] [Abstract][Full Text] [Related]
2. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
4. Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling.
Chen Q; Fan K; Chen X; Xie X; Huang L; Song G; Qi W
J Cell Mol Med; 2021 Oct; 25(19):9378-9389. PubMed ID: 34459110
[TBL] [Abstract][Full Text] [Related]
5. PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway.
Mao M; Chen Y; Jia Y; Yang J; Wei Q; Li Z; Chen L; Chen C; Wang L
J Cell Mol Med; 2019 Oct; 23(10):6930-6941. PubMed ID: 31448883
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
7. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
8. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
Chi F; Chen L; Jin X; He G; Liu Z; Han S
Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
[TBL] [Abstract][Full Text] [Related]
9. A novel role for ezrin in breast cancer angio/lymphangiogenesis.
Ghaffari A; Hoskin V; Szeto A; Hum M; Liaghati N; Nakatsu K; LeBrun D; Madarnas Y; Sengupta S; Elliott BE
Breast Cancer Res; 2014 Sep; 16(5):438. PubMed ID: 25231728
[TBL] [Abstract][Full Text] [Related]
10. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C
Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952
[TBL] [Abstract][Full Text] [Related]
11. Role for ezrin in breast cancer cell chemotaxis to CCL5.
Li J; Tu Y; Wen J; Yao F; Wei W; Sun S
Oncol Rep; 2010 Oct; 24(4):965-71. PubMed ID: 20811677
[TBL] [Abstract][Full Text] [Related]
12. 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.
Zheng S; Huang J; Zhou K; Zhang C; Xiang Q; Tan Z; Wang T; Fu X
PLoS One; 2011; 6(7):e22439. PubMed ID: 21818323
[TBL] [Abstract][Full Text] [Related]
13. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
14. Ezrin promotes invasion and metastasis of pancreatic cancer cells.
Meng Y; Lu Z; Yu S; Zhang Q; Ma Y; Chen J
J Transl Med; 2010 Jun; 8():61. PubMed ID: 20569470
[TBL] [Abstract][Full Text] [Related]
15. Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis.
Wang Y; Yang Y; Wang X; Jin T; Zhu G; Lin Z
J Gastroenterol Hepatol; 2021 Mar; 36(3):710-720. PubMed ID: 32710796
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).
Ma Q; Gao Y; Xu P; Li K; Xu X; Gao J; Qi Y; Xu J; Yang Y; Song W; He X; Liu S; Yuan X; Yin W; He Y; Pan W; Wei L; Zhang J
Biomed Res Int; 2019; 2019():3235021. PubMed ID: 31011573
[TBL] [Abstract][Full Text] [Related]
17. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
18. Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion.
Hoskin V; Szeto A; Ghaffari A; Greer PA; Côté GP; Elliott BE
Mol Biol Cell; 2015 Oct; 26(19):3464-79. PubMed ID: 26246600
[TBL] [Abstract][Full Text] [Related]
19. MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway.
Li Z; Li C; Wu Q; Tu Y; Wang C; Yu X; Li B; Wang Z; Sun S; Sun S
Cell Death Dis; 2021 Jan; 12(1):97. PubMed ID: 33462219
[TBL] [Abstract][Full Text] [Related]
20. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.
Mak H; Naba A; Varma S; Schick C; Day A; SenGupta SK; Arpin M; Elliott BE
BMC Cancer; 2012 Mar; 12():82. PubMed ID: 22397367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]